1912 related articles for article (PubMed ID: 31582403)
1. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
2. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
[TBL] [Abstract][Full Text] [Related]
4. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
6. m
Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
[TBL] [Abstract][Full Text] [Related]
7. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis.
Song C; Zhou C
J Exp Clin Cancer Res; 2021 Feb; 40(1):62. PubMed ID: 33563300
[TBL] [Abstract][Full Text] [Related]
8. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
9. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
[TBL] [Abstract][Full Text] [Related]
10. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated m
Huo FC; Zhu ZM; Zhu WT; Du QY; Liang J; Mou J
Oncogene; 2021 Apr; 40(16):2968-2981. PubMed ID: 33758320
[TBL] [Abstract][Full Text] [Related]
12. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
14. m
Liu Y; Zhai E; Chen J; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Cai S; Chen J
Cancer Commun (Lond); 2022 Apr; 42(4):327-344. PubMed ID: 35261206
[TBL] [Abstract][Full Text] [Related]
15. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
16. m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer.
Lin JX; Lian NZ; Gao YX; Zheng QL; Yang YH; Ma YB; Xiu ZS; Qiu QZ; Wang HG; Zheng CH; Li P; Xie JW; Lu J; Chen QY; Cao LL; Lin M; Wang JB; Huang CM
Cell Death Dis; 2022 May; 13(5):463. PubMed ID: 35568711
[TBL] [Abstract][Full Text] [Related]
17. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
[TBL] [Abstract][Full Text] [Related]
18. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m
He H; Wu W; Sun Z; Chai L
Biochem Biophys Res Commun; 2019 Oct; 517(4):581-587. PubMed ID: 31395342
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
20. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
